Apimeds Pharmaceuticals Files Q1 2025 10-Q
Ticker: APUS · Form: 10-Q · Filed: May 20, 2025 · CIK: 1894525
| Field | Detail |
|---|---|
| Company | Apimeds Pharmaceuticals Us, INC. (APUS) |
| Form Type | 10-Q |
| Filed Date | May 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Apimeds Pharma filed its Q1 2025 10-Q. Check financials.
AI Summary
Apimeds Pharmaceuticals US, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware with its principal executive offices in Hopewell, New Jersey, operates in the Pharmaceutical Preparations industry. The filing was made on May 20, 2025, under SEC file number 001-42545.
Why It Matters
This filing provides investors with an update on Apimeds Pharmaceuticals' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Players & Entities
- Apimeds Pharmaceuticals US, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- May 20, 2025 (date) — Filing date
- 001-42545 (other) — SEC File Number
- Delaware (other) — State of incorporation
- Hopewell, New Jersey (location) — Principal executive offices
FAQ
What is the primary business of Apimeds Pharmaceuticals US, Inc.?
Apimeds Pharmaceuticals US, Inc. operates in the Pharmaceutical Preparations industry, with a Standard Industrial Classification code of 2834.
When was the quarterly period covered by this 10-Q filing?
The quarterly period ended on March 31, 2025.
On what date was this Form 10-Q filed with the SEC?
This Form 10-Q was filed on May 20, 2025.
What is the SEC file number for Apimeds Pharmaceuticals US, Inc.?
The SEC file number for Apimeds Pharmaceuticals US, Inc. is 001-42545.
Where are the principal executive offices of Apimeds Pharmaceuticals US, Inc. located?
The principal executive offices are located at 2 East Broad Street, 2nd Floor, Hopewell, New Jersey, 08425.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding Apimeds Pharmaceuticals US, Inc. (APUS).